Bioresorbable Scaffolds Market Analysis by Types and Applications to Witness Robust Expansion at 18.9% by 2027

Bioresorbable Scaffolds Market
Recognizing the kind of growth the market is witnessing currently, Market Research Future (MRFR) recently published a study report asserting that the Bioresorbable Scaffolds Market will register a staggering CAGR of 18.9 % between 2018 and 2027 with Worldwide Top Players Abbott, BIOTRONIK, REVA Medical, Inc. etc.

Bioresorbable Scaffolds are like stents which are used during cardiovascular surgeries. They are valuable tools used for the treatment of different coronary diseases. According to WHO in 2014, approximately 18 million people died from cardiovascular diseases. Increasing prevalence of cardiovascular diseases, rising diabetic & obese population, and rapid development in technology have boosted this market’s growth. In addition to this, increasing stress, poor diet and lack of exercise have also contributed in the growth of this market. However, availability of alternative therapy may restrain this market’s growth.

The Global Bioresorbable Scaffolds Market is expected to grow at a CAGR of 18.9% during forecasted period 2017-2023.

Get sample report @

Bioresorbable Scaffolds Market – Key Players

Some of the key players in this market are:

  • Abbott Vascular (U.S.)
  • Biotronik (GER)
  • Kyoto Medical Planning Co. Ltd. (JP)
  • REVA Medical, Inc. (U.S.)
  • Xenogenics Corp. (U.S.)

Bioresorbable Scaffolds Market – Competitive Analysis

Well established players incorporate acquisition, collaboration, partnership, expansion, and product launch in order to gain competitive advantage in this market and to maintain their market position.

In April-2016, Abbott entered into a definitive agreement with St. Jude Medical Inc. which led to its acquisition. This created a premier medical device leader with top positions in high-growth cardiovascular markets, including atrial fibrillation, structural heart and heart failure as well as a leading position in the high-growth neuromodulation market. Under the agreement, St. Jude Medical shareholders received USD 46.75 in cash and 0.8708 shares of Abbott common stock, representing total consideration of approximately USD 85 per share. At an Abbott stock price of USd 43.93, this represented a total transaction equity value of USD 25 billion.

In June-2016, BIOTRONIK commercially launched of Solia S ProMRI, with a 5.6 French lead body, the smallest MR conditional pacing lead making it available in the U.S in 45, 53 and 60 centimeter lengths.

In July-2017, REVA Medical, Inc completed the reduction in its workforce in connection with the commercialization of its Fantom scaffold. A total of 11 full-time employees were let go, with 49 full-time employees remaining, in the transition from research and development activities to commercial activities. The Company estimates that it will incur aggregate cash charges of approximately USD 420,000 associated with the workforce reduction, comprising approximately USD 410,000 in severance payments and approximately USD 10,000 in continuation of benefits.

Bioresorbable Scaffolds Market – Segments

Global Bioresorbable Scaffolds Market has been segmented on the basis of types which comprises of Absorbable magnesium stent (AMS), Polymeric scaffold, poly carbonate scaffold, Poly salicylic acid stent, Myolimus-eluting Poly-L-Lactic acid scaffold, Everolimus-eluting Poly-L-lactic acid scaffold and others. On the basis of applications, the market is segmented into peripheral vascular intervention, regulation of blood flow and others. On the basis of end users, market is segmented into Hospitals, clinics, research institutes and others.

Bioresorbable Scaffolds Market – Regional Analysis

The Global Bioresorbable Scaffolds Market is dominated by America owing to the presence of huge population suffering from cardiovascular diseases, presence of number of leading companies and increasing geriatric population. Moreover, increasing obese and diabetic population, lack of exercise, increasing stress and desk-bound lifestyle has provided push for the growth of the market. Followed by the Americas, Europe has the second largest market due to the availability of huge research funds and increasing government support. Moreover, increasing healthcare expenditure along with the presence of developed economies like the Italy, Germany, France, and others within the region fuels the market growth within the region. Asia Pacific accounts for the fastest growing market due to the rapid development in technology, growing healthcare industry and a huge patient suffering. On the other hand, the Middle East & Africa accounts the least share in global Bioresorbable Scaffolds Market, especially due to the presence of poor economies within the African region.

Major Table of Content

Chapter 1. Report Prologue

Chapter 2. Market Introduction

2.1 Definition

2.2 Scope of the Study

2.2.1 Research Objective

2.2.2 Assumptions

2.2.3 Limitations

Chapter 3. Research Methodology

3.1 Introduction

3.2 Primary Research

3.3 Secondary Research

3.4 Market Size Estimation

Chapter 4. Market Dynamics


To Know More Enquire @

About Market Research Future:

At Market Research Future (MRFR), we enable our customers to unravel the complexity of various industries through our Cooked Research Report (CRR), Half-Cooked Research Reports (HCRR), Raw Research Reports (3R), Continuous-Feed Research (CFR), and Market Research & Consulting Services.

In order to stay updated with technology and work process of the industry, MRFR often plans & conducts meet with the industry experts and industrial visits for its research analyst members.

Media Contact
Company Name: Market Research Future
Contact Person: Abhishek Sawant
Email: Send Email
Phone: +1 646 845 9312
Address:Market Research Future Office No. 528, Amanora Chambers Magarpatta Road, Hadapsar
City: Pune
State: Maharashtra
Country: India